Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (China), China, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
55%
Total
Publications
244
Total Open
Publications
133
Total
Citations
10K
Open Access
Percentage
55%
Total
Publications
244
Total Open
Publications
133
Total
Citations
10K
Breakdown
Publisher Open
25%
Both
20%
Other Platform Open
9%
Closed
46%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 20%
22
Hybrid 33%
37
No Guarantees 47%
52
Other Platform Open
Domain 82%
58
Institution 21%
15
Other Internet 14%
10
Preprint 13%
9
Public 10%
7
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 58 |
Europe PMC | Domain | 34 |
Semantic Scholar | Public | 7 |
Research Square | Preprint | 5 |
Taylor and Francis Group - Dove Medical Press | Other Internet | 3 |
DOI | Other Internet | 3 |
The University of Manchester - Research Explorer | Institution | 2 |
Hokkaido University - Hokkaido University Collection of Scholarly and Academic Papers | Institution | 2 |
California Digital Library - eScholarship | Other Internet | 2 |
bioRxiv | Preprint | 2 |